| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Clinicopathologic Features of Prostate Cancer in Patients Diagnosed by Age 45 Who Underwent Radical Prostatectomy
DOI: 10.1016/j.eururo.2012.05.035
In recent years, the number of younger men being diagnosed with prostate cancer has increased . Several studies have compared the clinicopathologic features between men aged ≤50 yr versus older men, s...
|
Bonnie Choy,
Jennifer Gordetsky,
Hiroshi Miyamoto
|
Correspondence
(In Press Uncorrected Proof)
|
23 May 2012 |
|
Corrigendum to “Re: Kari A.O. Tikkinen, Anssi Auvinen. Does the Imprecise Definition of Overactive Bladder Serve Commercial Rather than Patient Interests? Eur Urol 2012;61:746–8. The Origin of the Term Overactive Bladder, Industry, and Patient Care” [Eur Urol 2012;61:749–50]
DOI: 10.1016/j.eururo.2012.05.019
The Conflict of interest statement is incorrect. The correct Conflict of interest statement is as follows:
|
Paul Abrams,
Alan Wein
|
Erratum
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Re: Oelke M, Giuliano F, Mirone V. Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. EUR UROL. 2012; 61:917–25.
DOI: 10.1016/j.eururo.2012.05.012
We thank the authors for conducting this randomized, placebo-controlled trial on effects of tadalafil or tamsulosin on lower urinary tract symptoms (LUTS) of benign prostatic hyperplasia (BPH) . The s...
|
Neeraj Kumar Goyal,
Apul Goel,
Rahul Yadav
|
Correspondence
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Re: Gacci M, Corona G, Salvi M et al. A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with a-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol 2012;61:994–1003
DOI: 10.1016/j.eururo.2012.05.022
We read the article by Gacci et al. with great interest . In this systematic review, three included trials compared different doses of phosphodiesterase type 5 inhibitors (PDE5-Is) with placebo, and e...
|
Jin-Qiu Yuan,
Zu-Yao Yang,
Chen Mao
|
Correspondence
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Reply to Neeraj Kumar Goyal, Apul Goel, Rahul Yadav's Letter to the Editor re: Matthias Oelke, François Giuliano, Vincenzo Mirone. Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial. Eur Urol 2012;61:917–25
DOI: 10.1016/j.eururo.2012.05.011
The authors of the recently published placebo-controlled trial on monotherapy of the phosphodiesterase 5 inhibitor tadalafil or the α1-blocker tamsulosin for the treatment of lower urinary tract sympt...
|
Matthias Oelke
|
Correspondence
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Reply to Jin-Qiu Yuan, Zu-Yao Yang, and Chen Mao's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Matteo Salvi, et al. A Systematic Review and Meta-Analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. Eur Urol 2012;61:994–1003
DOI: 10.1016/j.eururo.2012.05.020
We are pleased to respond to the comments about our paper, with the aim of resolving any doubts expressed by the clinicians interested in our review . Only a few papers regarding the use of phosphodie...
|
Mauro Gacci,
Giovanni Corona,
Matteo Monami,
Marco Carini,
Mario Maggi
et al.
|
Correspondence
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Reply from Authors re: Michel Bolla. The Moving Landscape of Locally Advanced Prostate Cancer: Combination of External Irradiation and Endocrine Treatment and/or Multimodal Approach. Eur Urol. In press. Locally advanced prostate cancer: optimal locoregional control matters
DOI: 10.1016/j.eururo.2012.05.010
Several years ago, the European Organization for Research and Treatment of Cancer 22863 trial initiated a new standard for locally advanced prostate cancer. Adding long-term systemic androgen-deprivat...
|
Nicholas Mottet,
Pierre Richaud
|
Editorial
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study
DOI: 10.1016/j.eururo.2012.05.032
Abstract: Background: The schedule for intravesical chemotherapy administration has not been definitively established in patients with low-grade recurrent non–muscle-invasive bladder cancer (NMIBC). O...
|
Renzo Colombo,
Lorenzo Rocchini,
Nazareno Suardi,
Fabio Benigni,
Giorgia Colciago,
Arianna Bettiga,
Federico Pellucchi,
Carmen Maccagnano,
Alberto Briganti,
Salonia Andrea,
Patrizio Rigatti,
Francesco Montorsi
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single centre Cohort with a Minimum Follow-up Time of 5 Years
DOI: 10.1016/j.eururo.2012.05.024
Abstract: Background: Robot-assisted radical prostatectomy (RARP) is an increasingly commonly used surgical treatment option for prostate cancer (PCa); however, its longer-term oncologic results remai...
|
Prasanna Sooriakumaran,
Leif Haendler,
Tommy Nyberg,
Henrik Gronberg,
Andreas Nilsson,
Stefan Carlsson,
Abolfazl Hosseini,
Christofer Adding,
Martin Jonsson,
Achilles Ploumidis,
Lars Egevad,
Gunnar Steineck,
Peter Wiklund
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer
DOI: 10.1016/j.eururo.2012.05.033
Abstract: Background: The prognostic value of CK20, Ki-67, and p53 has been investigated for non–muscle-invasive urothelial bladder cancers but not for the distinct and clinically challenging subset o...
|
Simone Bertz,
Wolfgang Otto,
Stefan Denzinger,
Wolf F. Wieland,
Maximilian Burger,
Robert Stöhr,
Stefan Link,
Ferdinand Hofstädter,
Arndt Hartmann
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Mapping of Pain Phenotypes in Female Patients with Bladder Pain Syndrome/Interstitial Cystitis and Controls
DOI: 10.1016/j.eururo.2012.05.023
Abstract: Background: Many bladder pain syndrome/interstitial cystitis (BPS/IC) patients report multiple pain locations outside the pelvis. No research has examined pain using a whole-body diagram, pa...
|
Dean A. Tripp,
J. Curtis Nickel,
Jennifer Wong,
Michel Pontari,
Robert Moldwin,
Robert Mayer,
Lesley K. Carr,
Ragi Doggweiler,
Claire C. Yang,
Nagendra Mishra,
Jorgen Nordling
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial
DOI: 10.1016/j.eururo.2012.05.025
Abstract: Background: Findings of studies on the association between androgens and prostate cancer (PCa) are mixed. Androgens may affect prostate-specific antigen (PSA) levels, thereby influencing bio...
|
Roberto L. Muller,
Leah Gerber,
Daniel M. Moreira,
Gerald Andriole,
Ramiro Castro,
Stephen J. Freedland
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
21 May 2012 |
|
Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis
DOI: 10.1016/j.eururo.2012.04.056
Abstract: Background: Previous randomised trials demonstrated that adjuvant radiation therapy (aRT) improves cancer control in patients with pT3 prostate cancer (PCa). However, there is currently no e...
|
Alberto Briganti,
Thomas Wiegel,
Steven Joniau,
Cesare Cozzarini,
Marco Bianchi,
Maxine Sun,
Bertrand Tombal,
Karin Haustermans,
Tom Budiharto,
Wolfgang Hinkelbein,
Nadia Di Muzio,
Pierre I. Karakiewicz,
Francesco Montorsi,
Hein Van Poppel
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
18 May 2012 |
|
Re: Xiao-Dong Jin, Simone Roethlisberger, Fiona C. Burkhard, Frédéric Birkhaeuser, Harriet C. Thoeny, Urs E. Studer. Long-term Renal Function After Urinary Diversion by Ileal Conduit or Orthotopic Ileal Bladder Substitution. Eur Urol 2012;61:491–7
DOI: 10.1016/j.eururo.2012.05.002
Jin et al. reported that diabetes and hypertension increase the risk of impaired renal function for ileal conduit rather than orthotopic ileal bladder substitution in patients surviving >10 yr . Ho...
|
Hao Lun Luo,
Yen Ta Chen,
Po Hui Chiang
|
Correspondence
(In Press Corrected Proof)
|
14 May 2012 |
|
Reply from Authors re: Hamilton RJ, Andriole GL, Freedland SJ. 5α-Reductase inhibitors: preventing the treatable. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.016
DOI: 10.1016/j.eururo.2012.05.004
We appreciate the opportunity to respond to the comments of Hamilton and colleagues . While we are pleased that our paper has initiated this dialogue, we note that these authors have overlooked the pr...
|
J. Kellogg Parsons,
Jeannette M. Schenk,
Kathryn B. Arnold,
Karen Messer,
Cathee Till,
Ian M. Thompson,
Alan R. Kristal,
for the Prostate Cancer Prevention Trial
et al.
|
Editorial
(In Press Uncorrected Proof)
|
14 May 2012 |
|
Reply from Authors re: Jens J. Rassweiler, Marie-Claire Rassweiler, Maurice-Stephan Michel. Classification of Complications: Is the Clavien-Dindo Classification the Gold Standard? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.028: The Boundary of Surgical Errors and Complications
DOI: 10.1016/j.eururo.2012.05.005
The quality of our scientific work may be regarded as an audit of our clinical work and consequently reflects our scientific integrity. The initiative to establish the Clinical Research Office of the ...
|
Jean J.M.C.H. de la Rosette,
Dedan Opondo
|
Editorial
(In Press Corrected Proof)
|
14 May 2012 |
|
Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial
DOI: 10.1016/j.eururo.2012.05.006
Abstract: Background: Several germline single nucleotide polymorphisms (SNPs) have been consistently associated with prostate cancer (PCa) risk. Objective: To determine whether there is an improvement...
|
A. Karim Kader,
Jielin Sun,
Brian H. Reck,
Paul J. Newcombe,
Seong-Tae Kim,
Fang-Chi Hsu,
Ralph B. D’Agostino,
Sha Tao,
Zheng Zhang,
Aubrey R. Turner,
Greg T. Platek,
Colin F. Spraggs,
John C. Whittaker,
Brian R. Lane,
William B. Isaacs,
Deborah A. Meyers,
Eugene R. Bleecker,
Frank M. Torti,
Jeffery M. Trent,
John D. McConnell,
S. Lilly Zheng,
Lynn D. Condreay,
Roger S. Rittmaster,
Jianfeng Xu
et al.
|
Full-length article
(In Press Uncorrected Proof)
|
14 May 2012 |
|
Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic Acid
DOI: 10.1016/j.eururo.2012.05.007
Abstract: Background: Zoledronic acid (ZOL) is a standard therapy for the prevention of skeletal-related events (SREs) in patients with castration-resistant prostate cancer (CRPC). Although prostate-s...
|
Fred Saad,
Scott Segal,
James Eastham
|
Full-length article
(In Press Uncorrected Proof)
|
14 May 2012 |
|
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature
DOI: 10.1016/j.eururo.2012.05.008
Abstract: Context: Follow-up of patients treated for bladder cancer (BCa) is of great importance for both non–muscle-invasive BCa (NMIBC) and muscle-invasive BCa (MIBC) because of the high incidence o...
|
Viktor Soukup,
Marko Babjuk,
Joaquim Bellmunt,
Guido Dalbagni,
Gianluca Giannarini,
Oliver W. Hakenberg,
Harry Herr,
Eric Lechevallier,
Maria J. Ribal
et al.
|
Review article
(In Press Corrected Proof)
|
14 May 2012 |
|
Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours
DOI: 10.1016/j.eururo.2012.05.009
Abstract: Context: The use of percutaneous biopsy of renal tumours has been traditionally reserved for selected cases because of uncertainties regarding its safety, accuracy, and clinical utility. Wit...
|
Alessandro Volpe,
Antonio Finelli,
Inderbir S. Gill,
Michael A.S. Jewett,
Guido Martignoni,
Thomas J. Polascik,
Mesut Remzi,
Robert G. Uzzo
et al.
|
Review article
(In Press Uncorrected Proof)
|
14 May 2012 |
|
Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer?
DOI: 10.1016/j.eururo.2012.05.003
Abstract: Background: Despite evidence that shows no survival advantage, many older patients receive primary androgen-deprivation therapy (PADT) shortly after the diagnosis of localized prostate cance...
|
Grace L. Lu-Yao,
Peter C. Albertsen,
Hui Li,
Dirk F. Moore,
Weichung Shih,
Yong Lin,
Robert S. DiPaola,
Siu-Long Yao
et al.
|
Full-length article
(In Press Corrected Proof)
|
14 May 2012 |
|
Neurovascular Structure-adjacent Frozen-section Examination (NeuroSAFE) Increases Nerve-sparing Frequency and Reduces Positive Surgical Margins in Open and Robot-assisted Laparoscopic Radical Prostatectomy: Experience After 11 069 Consecutive Patients
DOI: 10.1016/j.eururo.2012.04.057
Abstract: Background: Intraoperative frozen-section analysis allows real-time histologic assessment of surgical margins (SMs) and identification of candidates for nerve-sparing (NS) procedures. Object...
|
Thorsten Schlomm,
Pierre Tennstedt,
Caroline Huxhold,
Thomas Steuber,
Georg Salomon,
Uwe Michl,
Hans Heinzer,
Jens Hansen,
Lars Budäus,
Stefan Steurer,
Corinna Wittmer,
Sarah Minner,
Alexander Haese,
Guido Sauter,
Markus Graefen,
Hartwig Huland
et al.
|
Full-length article
(In Press Corrected Proof)
|
14 May 2012 |
|
Corrigendum to “The Importance of Interaction Between Urologists and Pathologists in Incidental Prostate Cancer Management” [Eur Eurol 2011;60;75–7]
DOI: 10.1016/j.eururo.2012.05.001
Affiliations a and d were incorrect. The correct affiliations are listed above.
|
Umberto Capitanio,
Liang Cheng,
Antonio Lopez-Beltran,
Marina Scarpelli,
Massimo Freschi,
Francesco Montorsi,
Rodolfo Montironi
et al.
|
Erratum
(In Press Corrected Proof)
|
10 May 2012 |
|
Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705–11
DOI: 10.1016/j.eururo.2012.04.054
We read with interest this article on long-term outcomes of selective bladder preservation using combined modality therapy . In the subgroup analysis by extent of transurethral resection of bladder tu...
|
Neeraj Kumar Goyal,
Manish Garg,
Apul Goel
|
Correspondence
(In Press Corrected Proof)
|
09 May 2012 |
|
Reply to Neeraj Kumar Goyal, Manish Garg, and Apul Goel's Letter to the Editor re: Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705–11
DOI: 10.1016/j.eururo.2012.04.055
We thank the authors of the letter to the editor for their insightful comments on our paper and agree that results of subgroup analyses must be heeded with caution. An incomplete transurethral resect...
|
Jason A. Efstathiou,
William U. Shipley,
Anthony L. Zietman
|
Correspondence
(In Press Corrected Proof)
|
07 May 2012 |
|
Stages of Prediction Model Comparison
DOI: 10.1016/j.eururo.2012.04.053
Risk prediction models can be assessed and compared on three fundamental levels: (1) discrimination, (2) calibration, and (3) utility. Unfortunately, it is rather difficult to identify commonly agreed...
|
Michael W. Kattan,
Thomas A. Gerds
|
Editorial
(In Press Corrected Proof)
|
07 May 2012 |
|
Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
DOI: 10.1016/j.eururo.2012.04.052
Abstract: Background: There is a lack of consensus regarding the optimal approach to the bladder cuff during radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Objectives: T...
|
Evanguelos Xylinas,
Michael Rink,
Eugene K. Cha,
Thomas Clozel,
Richard K. Lee,
Harun Fajkovic,
Evi Comploj,
Giacomo Novara,
Vitaly Margulis,
Jay D. Raman,
Yair Lotan,
Wassim Kassouf,
Hans-Martin Fritsche,
Alon Weizer,
Juan I. Martinez-Salamanca,
Kazumasa Matsumoto,
Richard Zigeuner,
Armin Pycha,
Douglas S. Scherr,
Christian Seitz,
Thomas Walton,
Quoc-Dien Trinh,
Pierre I. Karakiewicz,
Surena Matin,
Francesco Montorsi,
Marc Zerbib,
Shahrokh F. Shariat,
for the Upper Tract Urothelial Carcinoma Collaboration
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 May 2012 |
|
Safety Study of Umbilical Single-port Laparoscopic Radical Prostatectomy with a New DuoRotate System
DOI: 10.1016/j.eururo.2012.04.043
Abstract: Background: Laparoendoscopic single-site (LESS) radical prostatectomy (RP) has been performed through different approaches. A new DuoRotate manual system developed by Richard Wolf (KeyPort; ...
|
Felipe Cáceres,
Pedro M. Cabrera,
Ana García-Tello,
José M. García-Mediero,
Javier C. Angulo
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 May 2012 |
|
Critical Evaluation of the American Joint Committee on Cancer TNM Nodal Staging System in Patients with Lymph Node–Positive Disease after Radical Cystectomy
DOI: 10.1016/j.eururo.2012.04.050
Abstract: Background: The current 7th edition of the American Joint Committee on Cancer TNM staging system for bladder cancer stages lymph node (LN)–positive disease based on LN location rather than L...
|
H.M. Bruins,
Ryan P. Dorin,
Barbara Rubino,
Gus Miranda,
Jie Cai,
Siamak Daneshmand,
Eila C. Skinner
et al.
|
Full-length article
(In Press Corrected Proof)
|
07 May 2012 |
|
Photoselective Vaporisation of the Prostate Using 80-W and 120-W Laser Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Systematic Review with Meta-Analysis from 2002 to 2012
DOI: 10.1016/j.eururo.2012.04.051
Abstract: Context: Photoselective vaporisation (PVP) of the prostate is being used increasingly to treat symptomatic benign prostatic hyperplasia, due to the associated lower morbidity. Holmium laser ...
|
Isaac A. Thangasamy,
Venu Chalasani,
Alexander Bachmann,
Henry H. Woo
|
Review article
(In Press Corrected Proof)
|
07 May 2012 |
|
Adhesion Blockers: A Paradigm Shift in the Treatment of Urinary Tract Infections
DOI: 10.1016/j.eururo.2012.04.045
Interactions between host and uropathogens play a pivotal role in initiation, development, maintenance, and recurrence of urinary tract infections (UTIs). In the era of increasing antimicrobial resist...
|
Massimo Lazzeri,
Giorgio Guazzoni,
Francesco Montorsi
|
Correspondence
(In Press Corrected Proof)
|
04 May 2012 |
|
Reply to Santhanam Sundar's Letter to the Editor re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009–18
DOI: 10.1016/j.eururo.2012.04.042
The members of the Muscle-invasive and Metastatic Bladder Cancer (MIMBC) section of the European Association of Urology Clinical Guidelines group are always open to and thankful for discussions regard...
|
Arnulf Stenzl,
Nigel C. Cowan,
Maria De Santis,
Markus A. Kuczyk,
Axel S. Merseburger,
Maria José Ribal,
Amir Sherif,
J. Alfred Witjes,
Thierry Lebret
et al.
|
Correspondence
(In Press Corrected Proof)
|
04 May 2012 |
|
European Association of Urology Guidelines on Male Infertility: The 2012 Update
DOI: 10.1016/j.eururo.2012.04.048
Abstract: Context: New data regarding the diagnosis and treatment of male infertility have emerged and led to an update of the European Association of Urology (EAU) guidelines for Male Infertility. Ob...
|
Andreas Jungwirth,
Aleksander Giwercman,
Herman Tournaye,
Thorsten Diemer,
Zsolt Kopa,
Gert Dohle,
Csilla Krausz,
EAU Working Group on Male Infertility
et al.
|
Practice guideline
(In Press Corrected Proof)
|
04 May 2012 |
|
Increasing Risk of Infectious Complications After Transrectal Ultrasound–Guided Prostate Biopsies: Time to Reassess Antimicrobial Prophylaxis?
DOI: 10.1016/j.eururo.2012.04.044
Abstract: Background: An increasing risk of infectious complications following transrectal ultrasound–guided prostate needle biopsy (PNB) has been observed recently in some centers. Objective: To deli...
|
Alex Carignan,
Jean-François Roussy,
Véronique Lapointe,
Louis Valiquette,
Robert Sabbagh,
Jacques Pépin
et al.
|
Full-length article
(In Press Corrected Proof)
|
04 May 2012 |
|
A Review of Integrated Staging Systems for Renal Cell Carcinoma
DOI: 10.1016/j.eururo.2012.04.049
Abstract: Context: Several outstanding integrated staging systems (ISSs) have been devised for patients with renal cell carcinoma (RCC). Objective: To review the available literature on existing ISSs....
|
Malek Meskawi,
Maxine Sun,
Quoc-Dien Trinh,
Marco Bianchi,
Jens Hansen,
Zhe Tian,
Michael Rink,
Salima Ismail,
Shahrokh F. Shariat,
Francesco Montorsi,
Paul Perrotte,
Pierre I. Karakiewicz
et al.
|
Review article
(In Press Corrected Proof)
|
04 May 2012 |
|
Prevention and Management of Postprostatectomy Sexual Dysfunctions Part 1: Choosing the Right Patient at the Right Time for the Right Surgery
DOI: 10.1016/j.eururo.2012.04.046
Abstract: Context: Sexual dysfunction is common in patients following radical prostatectomy (RP) for prostate cancer (PCa). Objective: To review the available literature concerning prevention and mana...
|
Andrea Salonia,
Arthur L. Burnett,
Markus Graefen,
Kostas Hatzimouratidis,
Francesco Montorsi,
John P. Mulhall,
Christian Stief
et al.
|
Review article
(In Press Corrected Proof)
|
04 May 2012 |
|
Prevention and Management of Postprostatectomy Sexual Dysfunctions Part 2: Recovery and Preservation of Erectile Function, Sexual Desire, and Orgasmic Function
DOI: 10.1016/j.eururo.2012.04.047
Abstract: Context: Sexual dysfunction is common in patients who undergo radical prostatectomy (RP) for prostate cancer (PCa). Objective: Review the available literature concerning prevention of, and m...
|
Andrea Salonia,
Arthur L. Burnett,
Markus Graefen,
Kostas Hatzimouratidis,
Francesco Montorsi,
John P. Mulhall,
Christian Stief
et al.
|
Review article
(In Press Corrected Proof)
|
04 May 2012 |
|
Comparison of Three Different Tools for Prediction of Seminal Vesicle Invasion at Radical Prostatectomy
DOI: 10.1016/j.eururo.2012.04.022
Abstract: Background: Statistical prediction tools are increasingly common, but there is considerable disagreement about how they should be evaluated. Three tools—Partin tables, the European Society f...
|
Giovanni Lughezzani,
Kevin C. Zorn,
Lars Budäus,
Maxine Sun,
David I. Lee,
Arieh L. Shalhav,
Gregory P. Zagaya,
Sergey A. Shikanov,
Ofer N. Gofrit,
Alan E. Thong,
David M. Albala,
Leon Sun,
Angel Cronin,
Andrew J. Vickers,
Pierre I. Karakiewicz
et al.
|
Full-length article
(In Press Corrected Proof)
|
03 May 2012 |
|
Reply from Authors re: Quoc-Dien Trinh, Khurshid R. Ghani, Mani Menon. Robot assisted radical prostatectomy: ready to be counted? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.03.014: Walking the Tightrope: Balancing Cancer Control, Urinary Continence, and Sexual Function—A Programmatic Evolution
DOI: 10.1016/j.eururo.2012.04.041
Thanks for the opportunity to respond to the editorial comments presented by Trinh et al. . We appreciate the thoughts on the methodology of meta-analysis. This methodology is robust and gives us a go...
|
Ashutosh Tewari,
Anthony Pham,
Abhishek Srivastava,
Robert Leung,
Prasanna Sooriakumaran,
Dan Bloch,
Usha Seshadri-Kreaden,
April E. Hebert,
Peter Wiklund
et al.
|
Editorial
(In Press Corrected Proof)
|
30 April 2012 |
|
The Moving Landscape of Locally Advanced Prostate Cancer: Combination of External Irradiation and Endocrine Treatment and/or Multimodal Approach
DOI: 10.1016/j.eururo.2012.04.040
The pioneering results of the European Organization for Research and Treatment of Cancer and the Radiation Therapy Oncology Group trials devoted to locally advanced prostate cancer (PCa) have shown ...
|
Michel Bolla
|
Editorial
(In Press Corrected Proof)
|
26 April 2012 |
|
Re: Shahrokh F. Shariat, Behfar Ehdaie, Michael Rink, et al. Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment. Eur Urol 2012;61:237–42
DOI: 10.1016/j.eururo.2012.04.039
We were surprised when reading the paper from Shariat et al. in which the authors conclude that the extent of pelvic lymph node dissection (PLND) in radical cystectomy patients should be adapted to t...
|
Urs E. Studer,
Richard Sylvester
|
Correspondence
(In Press Corrected Proof)
|
25 April 2012 |
|
Toward a Better Understanding of Kidney Stone Disease: Platinum Priorities
DOI: 10.1016/j.eururo.2012.04.027
Kidney stones are a common and costly disease, and our epidemiologic understanding is continuing to evolve. In their broadest terms, epidemiologic investigations describe a wide range of scientific ef...
|
Brian R. Matlaga
|
Editorial
(In Press Corrected Proof)
|
23 April 2012 |
|
Reply from Authors re: Jose A. Karam, Christopher G. Wood. The Effects of Temporary Ischemia in Partial Nephrectomy on Renal Functional Outcomes: How Can Effects Best Be Estimated and Can They Be Mitigated? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.058
DOI: 10.1016/j.eururo.2012.04.038
Renal function after a partial nephrectomy (PN) depends on the residual kidney quality and quantity . Unfortunately, surgeons can change neither tumour size nor the baseline glomerular filtration rate...
|
Francesco Porpiglia,
Cristian Fiori
|
Editorial
(In Press Corrected Proof)
|
23 April 2012 |
|
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery
DOI: 10.1016/j.eururo.2012.04.037
Abstract: Background: Information on autonomic neurapraxia in female urogenital surgery is scarce, and a model to study it is not available. Objective: To develop a model to study the impact of autono...
|
Fabio Castiglione,
Alice Bergamini,
Arianna Bettiga,
Trinity J. Bivalacqua,
Fabio Benigni,
Frank Strittmatter,
Giorgio Gandaglia,
Patrizio Rigatti,
Francesco Montorsi,
Petter Hedlund
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 April 2012 |
|
Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial
DOI: 10.1016/j.eururo.2012.04.024
Abstract: Background: Although there is randomized evidence that radical prostatectomy improves survival, there are few data on how benefit varies by baseline risk. Objective: We aimed to create a sta...
|
Andrew Vickers,
Caroline Bennette,
Gunnar Steineck,
Hans-Olov Adami,
Jan-Erik Johansson,
Anna Bill-Axelson,
Juni Palmgren,
Hans Garmo,
Lars Holmberg
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 April 2012 |
|
Does Comorbidity Influence the Risk of Myocardial Infarction or Diabetes During Androgen-Deprivation Therapy for Prostate Cancer?
DOI: 10.1016/j.eururo.2012.04.035
Abstract: Background: Androgen-deprivation therapy (ADT) for prostate cancer (PCa) may be associated with cardiovascular disease and diabetes. Some data suggest that men with certain conditions may be...
|
Nancy L. Keating,
A. James O’Malley,
Stephen J. Freedland,
Matthew R. Smith
|
Full-length article
(In Press Corrected Proof)
|
20 April 2012 |
|
Occlusion of Seminal Vesicles Increases Sexual Activity in a Mouse Model
DOI: 10.1016/j.eururo.2012.04.036
Abstract: Background: Little is known about the physiologic role of seminal vesicles beyond their fertility function. It has been suggested repeatedly that seminal vesicles have an impact on sexual ac...
|
Frédéric D. Birkhäuser,
Celine Schumacher,
Roland Seiler,
Louis de Meuron,
Pascal Zehnder,
Beat Roth,
Antoinette Wetterwald,
George N. Thalmann,
Marco G. Cecchini,
Urs E. Studer
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 April 2012 |
|
Re: Giorgio Guazzoni, Massimo Lazzeri, Luciano Nava, et al. Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer. Eur Urol 2012;61:455–66
DOI: 10.1016/j.eururo.2012.04.030
We read with great interest the recent paper of Guazzoni and colleagues on the prediction of prostate cancer (PCa) characteristics at final pathology with preoperative prostate-specific antigen (PSA)...
|
Sergey Tadtayev,
Thomas A. McNicholas,
Gregory B. Boustead
|
Correspondence
(In Press Corrected Proof)
|
19 April 2012 |
|
Re: Alexander Kutikov, Boris Rozenfeld, Brian L. Egleston, et al. Academic Ranking Score: A Publication-Based Reproducible Metric of Thought Leadership in Urology. Eur Urol 2012;61:435–9
DOI: 10.1016/j.eururo.2012.04.026
We read the recent article by Kutikov et al. with interest and skepticism. The authors are critical of subjectivity in the reputational score within the US News and World Report (USNWR) hospital rank...
|
Elias S. Hyams,
Jeffrey K. Mullins,
Mohamad E. Allaf
|
Correspondence
(In Press Corrected Proof)
|
19 April 2012 |
|
Prospective Evaluation of Molecular Markers for the Staging and Prognosis of Upper Tract Urothelial Carcinoma
DOI: 10.1016/j.eururo.2012.04.031
The prognostic utility of biomarkers is well studied in bladder cancer with tissue-based molecular markers demonstrating the ability to predict disease progression in non–muscle-invasive tumors and pa...
|
Aditya Bagrodia,
Ramy F. Youssef,
Payal Kapur,
Oussama M. Darwish,
Chase Cannon,
Michael J. Belsante,
Deniz Gerecci,
Arthur I. Sagalowsky,
Shahrokh F. Shariat,
Yair Lotan,
Vitaly Margulis
et al.
|
Correspondence
(In Press Corrected Proof)
|
19 April 2012 |
|
Onabotulinumtoxin A for Idiopathic Overactive Bladder: Raising the Bar
DOI: 10.1016/j.eururo.2012.04.033
OnabotulinumtoxinA (BoNT-ONA) is approved in approximately 75 countries worldwide. The indication for its use ranges from treatment of frown lines between the brows, severe axillary hyperhidrosis, cer...
|
Ricarda M. Bauer,
Christian Gratzke
|
Editorial
(In Press Corrected Proof)
|
19 April 2012 |
|
Histologic Variants of Upper Tract Urothelial Carcinoma Do Not Affect Response to Adjuvant Chemotherapy After Radical Nephroureterectomy
DOI: 10.1016/j.eururo.2012.04.023
Radical nephroureteretomy (RNU) with excision of the bladder cuff is the standard of care for patients with high-risk urothelial carcinoma of the upper tract (UTUC) . Despite its durable long-term dis...
|
Evanguelos Xylinas,
Michael Rink,
Vitaly Margulis,
Pierre I. Karakiewicz,
Karim Bensalah,
Shahrokh F. Shariat,
for the Upper Tract Urothelial Carcinoma Collaboration
et al.
|
Correspondence
(In Press Corrected Proof)
|
19 April 2012 |
|
Reply from Authors re: Mark Emberton. Tissue Preservation May Offer a Harm-Reduction Strategy for Men with Early Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.03.043: Key to Successful Focal Therapy: Location, Location, Location
DOI: 10.1016/j.eururo.2012.04.034
In contemporary practice, many solid organ cancers (kidney, liver, breast) undergo targeted cancer destruction/excision while preserving adjacent healthy tissue. Reliable radiologic identification of ...
|
Osamu Ukimura,
Inderbir S. Gill
|
Editorial
(In Press Corrected Proof)
|
19 April 2012 |
|
Classification of Complications: Is the Clavien-Dindo Classification the Gold Standard?
DOI: 10.1016/j.eururo.2012.04.028
We congratulate de la Rosette et al. for focusing on the practicability of standardised documentation of complications following percutaneous nephrolithotomy (PCNL) . The Clinical Research Office of t...
|
Jens J. Rassweiler,
Marie-Claire Rassweiler,
Maurice-Stephan Michel
|
Editorial
(In Press Corrected Proof)
|
19 April 2012 |
|
Reply to Sergey Tadtayev, Thomas A. McNicholas, and Gregory B. Boustead's Letter to the Editor re: Giorgio Guazzoni, Massimo Lazzeri, Luciano Nava, et al. Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer. Eur Urol 2012;61:455–66
DOI: 10.1016/j.eururo.2012.04.029
We have been gratified by the interest generated by our paper on the prediction of pathologic outcomes using prostate-specific antigen (PSA) serum isoform [-2]proPSA (p2PSA) and its derivative paramet...
|
Massimo Lazzeri,
Giovanni Lughezzani,
Alessandro Larcher,
Giuliana Lista,
Giulio Maria Gadda,
Vincenzo Scattoni,
Andrea Cestari,
Nicolòmaria Buffi,
Patrizio Rigatti,
Francesco Montorsi,
Giorgio Guazzoni
et al.
|
Correspondence
(In Press Corrected Proof)
|
19 April 2012 |
|
Reply to Elias S. Hyams, Jeffrey K. Mullins, and Mohamad E. Allaf's Letter to the Editor re: Alexander Kutikov, Boris Rozenfeld, Brian L. Egleston, et al. Academic Ranking Score: A Publication-Based Reproducible Metric of Thought Leadership in Urology. Eur Urol 2012;61:435–9
DOI: 10.1016/j.eururo.2012.04.025
We appreciate the comments of Hyams et al. regarding our recent manuscript describing the Academic Ranking Score (ARS), an initial attempt to create an objective measure of thought leadership in urolo...
|
Alexander Kutikov,
Robert G. Uzzo
|
Correspondence
(In Press Corrected Proof)
|
19 April 2012 |
|
Robotic Transrectal Ultrasonography During Robot-Assisted Radical Prostatectomy
DOI: 10.1016/j.eururo.2012.04.032
Abstract: We evaluate the use of robotically manipulated transrectal ultrasound (TRUS) for real-time monitoring of prostate and periprostatic anatomy during robot-assisted prostatectomy (RAP). Ten pat...
|
Andrew J. Hung,
André Luís De Castro Abreu,
Sunao Shoji,
Alvin C. Goh,
Andre K. Berger,
Mihir M. Desai,
Monish Aron,
Inderbir S. Gill,
Osamu Ukimura
et al.
|
Short survey
(In Press Corrected Proof)
|
19 April 2012 |
|
Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center
DOI: 10.1016/j.eururo.2012.04.020
Abstract: Background: Small cell urothelial carcinoma (SCUC) is a rare, aggressive malignancy with a propensity for early microscopic metastases. Data suggest that neoadjuvant chemotherapy may lead to...
|
Siobhan P. Lynch,
Yu Shen,
Ashish Kamat,
H. Barton Grossman,
Jay B. Shah,
Randall E. Millikan,
Colin P. Dinney,
Arlene Siefker-Radtke
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 April 2012 |
|
Corrigendum to “Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer” [Eur Urol 2012;61:972–93]
DOI: 10.1016/j.eururo.2012.04.003
An incorrect affiliation b for the 3rd and 6th authors was given in the paper. It has been corrected above.
|
Steven MacLennan,
Mari Imamura,
Marie C. Lapitan,
Muhammad Imran Omar,
Thomas B.L. Lam,
Ana M. Hilvano-Cabungcal,
Pam Royle,
Fiona Stewart,
Graeme MacLennan,
Sara J. MacLennan,
Steven E. Canfield,
Sam McClinton,
T.R. Leyshon Griffiths,
Börje Ljungberg,
James N’Dow,
UCAN Systematic Review Reference Group
et al.
|
Erratum
(In Press Corrected Proof)
|
16 April 2012 |
|
Re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002
DOI: 10.1016/j.eururo.2012.04.001
Bul et al. intend to optimize the active surveillance modality using the outcome data from their large radical prostatectomy series, that is, they try to distinguish cases with unfavorable outcomes b...
|
Ferhat Ates,
Ilker Akyol,
Hasan Soydan
|
Correspondence
(In Press Corrected Proof)
|
16 April 2012 |
